Therefore, we conclude that miRs-135a-5p and -138-5p and the evaluation of pY397-FAK in the membrane and cytoplasmic compartment could be a new promising potent tool for guiding thyroid cancer management. The gene discussed is PTK2; the disease is thyroid gland carcinoma.